Publikationen der Medizinischen Klinik I 2014

Kommentare oder Korrespondenzen

1. Finkelmeier F, Kronenberger B, Köberle V, Bojunga J, Zeuzem S, Trojan J, Piiper A, Waidmann O (2014) Commentary: vitamin D deficiency and liver cancer - cause, effect or myth? Authors' reply. ALIMENT PHARM THER, 39 (12): 1429-30

2. Wiegand J, Maasoumy B, Buggisch P, Buslau A, Schiefke I, Berg T, Wedemeyer H, Sarrazin C, Hinrichsen H (2014) Letter: Telaprevir triple therapy in chronic hepatitis C genotype 1 patients receiving haemodialysis. ALIMENT PHARM THER, 39 (11): 1342-4

Originalarbeiten

1. Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, Romero-Gomez M, Zarski JP, Agarwal K, Buggisch P, Foster GR, Bräu N, Buti M, Jacobson IM, Subramanian GM, Ding X, Mo H, Yang JC, Pang PS, Symonds WT, McHutchison JG, Muir AJ, Mangia A, Marcellin P, ION-1 Investigators (2014) Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. NEW ENGL J MED, 370 (20): 1889-98

2. Akoglu B, Lafferton B, Kalb S, Yosuf SE, Herrmann E, Zeuzem S, Goßmann J, Kachel HG, Scheuermann EH, Faust D (2014) Rejection quantity in kidney transplant recipients is associated with increasing intracellular interleukin-2 in CD8+ T-cells. TRANSPL IMMUNOL, 31 (1): 17-21

3. Albert JG, Finkelmeier F, Friedrich-Rust M, Kronenberger B, Trojan J, Zeuzem S, Sarrazin C (2014) Identifying Indications for Percutaneous (PTC) vs. Endoscopic Ultrasound (EUS)- Guided "Rendezvous" Procedure in Biliary Obstruction and Incomplete Endoscopic Retrograde Cholangiography (ERC). Z GASTROENTEROL, 52 (10): 1157- 1163

4. Alao JP1, Sjölander JJ, Baar J, Özbaki-Yagan N, Kakoschky B, Sunnerhagen P. Caffeine stabilizes Cdc25 independently of Rad3 in Schizosaccharomyces pombe contributing to checkpoint override. Mol Microbiol. 2014 May;92(4):777-96

5. Albert JG, Lucas K, Filmann N, Herrmann E, Schröder O, Sarrazin C, Trojan J, Kronenberger B, Bojunga J, Zeuzem S, Friedrich-Rust M (2014) A novel, stiff-shaft, flexible-tip guidewire for cannulation of biliary stricture during endoscopic retrograde cholangiopancreatography: a randomized trial. ENDOSCOPY, 46 (10): 857-61

6. Albert JG, Tal A, Bechstein WO, Trojan J, Schnitzbauer A (2014) Three late adverse events of choledochoduodenostomy of which the endoscopist should be aware: direct retrograde cholangioscopy is helpful for diagnosis and therapy. GASTROINTEST ENDOSC, -: -

7. Arama V, Leblebicioglu H, Simon K, Zarski JP, Niederau C, Habersetzer F, Vermehren J, Bludzin W, Jinga M, Ulusoy S, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Zeuzem S, the AI, European Longitudinal Chronic Hepatitis B Study Group (2014) Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies. ANTIVIR THER, -: -

8. Arends P, Sonneveld MJ, Zoutendijk R, Carey I, Brown A, Fasano M, Mutimer D, Deterding K, Reijnders JGP, Oo Y, Petersen J, van Bömmel F, de Knegt RJ, Santantonio T, Berg T, Welzel TM, Wedemeyer H, Buti M, Pradat P, Zoulim F, Hansen B, Janssen HLA, for the VIRGIL Surveillance Study Group (2014) Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians. GUT, -: -

9. Badenhoop K (2014) Genetics: Vitamin D and type 2 diabetes mellitus-hype or hope? NAT REV ENDOCRINOL, -: -

10. Bajer MM, Kunze MM, Blees JS, Bokesch HR, Chen H, Brauss TF, Dong Z, Gustafson KR, Biondi RM, Henrich CJ, 
McMahon JB, Colburn NH, Schmid T, Brüne B (2014) Characterization of pomiferin triacetate as a novel mTOR and 
translation inhibitor. BIOCHEM PHARMACOL, 88 (3): 313-21

11. Bergis D, Bergis PM, Hermanns N, Zink K, Haak T (2014) Coronary artery disease as an independent predictor of 
survival in patients with type 2 diabetes and Charcot neuro-osteoarthropathy. ACTA DIABETOL, 51 (6): 1041-8

12. Berg T, Andreone P, Pol S, Roberts S, Younossi Z, Diago M, Lawitz EJ, Focaccia R, Foster GR, Horban A, Lonjon- Domanec I, DeMasi R, Picchio G, Luo D, De Meyer S, Zeuzem S (2014) Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study. LIVER 
INT, -: -

13. Blumenstein I, Dignass A, Vollmer S, Klemm W, Weber-Mangal S, Stein J (2014) Current practice in the diagnosis and 
management of IBD-associated anaemia and iron deficiency in Germany: the German AnaemIBD Study. J CROHNS 
COLITIS, 8 (10): 1308-14

14. Blumenstein I, Shastri YM, Stein J (2014) Gastroenteric tube feeding: techniques, problems and solutions. WORLD J 
GASTROENTERO, 20 (26): 8505-24

15. Boursier J, de Ledinghen V, Poynard T, Guéchot J, Carrat F, Leroy V, Wong GLH, Friedrich-Rust M, Fraquelli M, 
Plebani M, Sebastiani G, Myers R, Angulo P, Bertrais S, Wendum D, Bricault I, Calès P, from the ARDENT group and/or AFEF (2014) An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standards. J HEPATOL, -: -

16. Brouwer WP, Sonneveld MJ, Tabak F, Simon K, Cakaloglu Y, Akarca US, Zeuzem S, Ferenci P, Heathcote JE, de Knegt RJ, Boonstra A, Hansen BE, Janssen HLA (2014) Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B. ALIMENT PHARM THER, 40 (7): 811-8

17. Bruggmann P, Berg T, Øvrehus ALH, Moreno C, Brandão Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, Akarca U, Balık I, Bihl F, Bilodeau M, Blasco AJ, Buti M, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HSM, Cornberg M, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Ferraz MLG, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KDE, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Mauss S, Mendes Correa MC, Müllhaupt B, Myers RP, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Rosenberg WM, Sarmento-Castro R, Sarrazin C, Semela D, Shiha GE, Sievert W, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, van Thiel I, Van Vlierberghe H, Vandijck D, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Hindman SJ (2014) Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat, 21 Suppl 1: 5-33

18. Buti M, Agarwal K, Horsmans Y, Sievert W, Janczewska E, Zeuzem S, Nyberg L, Brown RS, Hezode C, Rizzetto M, Parana R, De Meyer S, De Masi R, Luo D, Bertelsen K, Witek J (2014) Telaprevir Twice Daily is Noninferior to Telaprevir Every 8 hrs for Patients with Chronic Hepatitis C. GASTROENTEROLOGY, 146 ((3)): 744-753

19. Canbay A, Feldstein A, Kronenberger B, Schulze-Osthoff K, Bantel H (2014) [Cytokeratin 18 as marker for non- invasive diagnosis and prognosis of acute and chronic liver diseases]. Z GASTROENTEROL, 52 (3): 290-5

20. Cloherty G, Cohen D, Sarrazin C, Wedemeyer H, Chevaliez S, Herman C, Bernstein B, Pawlotsky JM (2014) HCV RNA assay sensitivity impacts the management of patients treated with direct-acting antivirals. ANTIVIR THER, -: -

21. Dawoodji A, Chen JL, Shepherd D, Dalin F, Tarlton A, Alimohammadi M, Penna-Martinez M, Meyer G, Mitchell AL, 
Gan EH, Bratland E, Bensing S, Husebye ES, Pearce SH, Badenhoop K, Kämpe O, Cerundolo V (2014) High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients. J IMMUNOL, 193 (5): 2118-26

22. de Boer YS, van Gerven NMF, Zwiers A, Verwer BJ, van Hoek B, van Erpecum KJ, Beuers U, van Buuren HR, Drenth JPH, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MMJ, Vrolijk JM, Kraal G, Mulder CJJ, van Nieuwkerk CMJ, Fischer J, Berg T, Stickel F, Sarrazin C, Schramm C, Lohse AW, Weiler-Normann C, Lerch MM, Nauck M, Völzke H, Homuth G, Bloemena E, Verspaget HW, Kumar V, Zhernakova A, Wijmenga C, Franke L, Bouma G, Dutch Autoimmune Hepatitis Study Group, LifeLines Cohort Study, Study of Health in Pomerania (2014) Genome- wide association study identifies variants associated with autoimmune hepatitis type 1. GASTROENTEROLOGY, 147 (2): 443-52.e5

23. Doller A, Badawi A, Schmid T, Brauß T, Pleli T, Zu Heringdorf DM, Piiper A, Pfeilschifter J, Eberhardt W (2014) The cytoskeletal inhibitors latrunculin A and blebbistatin exert antitumorigenic properties in human hepatocellular carcinoma cells by interfering with intracellular HuR trafficking. EXP CELL RES, -: -

24. Döring G, Bragonzi A, Paroni M, Aktürk FF, Cigana C, Schmidt A, Gilpin D, Heyder S, Born T, Smaczny C, Kohlhäufl M, Wagner TOF, Loebinger MR, Bilton D, Tunney MM, Elborn JS, Pier GB, Konstan MW, Ulrich M (2014) BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs. J CYST FIBROS, 13 ((2)): 156-63

25. Doerrbecker J, Friesland M, Riebesehl N, Ginkel C, Behrendt P, Brown RJP, Ciesek S, Wedemeyer H, Sarrazin C, Kaderali L, Pietschmann T, Steinmann E (2014) Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles. HEPATOLOGY, 60 (2): 508-20

26. Dultz G, Gerber L, Farnik H, Berger A, Vermehren J, Pleli T, Zeuzem S, Piiper A, Kronenberger B, Waidmann O (2014) Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus. J Viral Hepat, -: -

27. Everson G, Cooper C, Hézode C, Shiffman ML, Yoshida E, Beltran-Jaramillo T, Andreone P, Bruno S, Ferenci P, Zeuzem S, Brunda M, Le Pogam S, Nájera I, Zhou J, Navarro MT, Voulgari A, Shulman NS, Yetzer ES (2014) DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4. LIVER INT, -: -

28. Farnik H, Ferreirós N, Labocha S, Geisslinger G, Zeuzem S, Sarrazin C, Vermehren J (2014) Role of telaprevir plasma levels for predicting response to antiviral therapy in patients with hepatitis C virus genotype 1 infection. SCAND J GASTROENTERO, 49 (12): 1473-9

29. Farnik H, Weigt J, Malfertheiner P, Grützmann A, Gossner L, Friedrich-Rust M, Zeuzem S, Sarrazin C, Albert JG (2014) A multicenter study on the role of direct retrograde cholangioscopy in patients with inconclusive endoscopic retrograde cholangiography. ENDOSCOPY, 46 (1): 16-21

30. Farnik H, Zimmermann T, Herrmann E, Bechstein WO, Kronenberger B, Galle PR, Labocha S, Ferreiros N, Geisslinger G, Zeuzem S, Sarrazin C, Welker MW (2014) Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation. LIVER INT, -: -

31. Fevery B, Susser S, Lenz O, Cloherty G, Perner D, Picchio G, Sarrazin C (2014) HCV RNA quantification with different assays: implications for protease-inhibitor-based response-guided therapy. ANTIVIR THER, -: -